Cargando…

Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters

Epigallocatechin-3-O-gallate (EGCG) is the major catechin component of green tea (Cameria sinensis), and is known to possess antiviral activities against a wide range of DNA viruses and RNA viruses. However, few studies have examined chemical modifications of EGCG in terms of enhanced antiviral effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaihatsu, Kunihiro, Yamabe, Miyuki, Ebara, Yasuhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222519/
https://www.ncbi.nlm.nih.gov/pubmed/30262731
http://dx.doi.org/10.3390/molecules23102475
_version_ 1783369224293449728
author Kaihatsu, Kunihiro
Yamabe, Miyuki
Ebara, Yasuhito
author_facet Kaihatsu, Kunihiro
Yamabe, Miyuki
Ebara, Yasuhito
author_sort Kaihatsu, Kunihiro
collection PubMed
description Epigallocatechin-3-O-gallate (EGCG) is the major catechin component of green tea (Cameria sinensis), and is known to possess antiviral activities against a wide range of DNA viruses and RNA viruses. However, few studies have examined chemical modifications of EGCG in terms of enhanced antiviral efficacy. This paper discusses which steps of virus infection EGCG interferes with, citing previous reports. EGCG appears most likely to inhibits the early stage of infections, such as attachment, entry, and membrane fusion, by interfering with viral membrane proteins. According to the relationships between structure and antiviral activity of catechin derivatives, the 3-galloyl and 5′-OH group of catechin derivatives appear critical to antiviral activities. Enhancing the binding affinity of EGCG to virus particles would thus be important to increase virucidal activity. We propose a newly developed EGCG-fatty acid derivative in which the fatty acid on the phenolic hydroxyl group would be expected to increase viral and cellular membrane permeability. EGCG-fatty acid monoesters showed improved antiviral activities against different types of viruses, probably due to their increased affinity for virus and cellular membranes. Our study promotes the application of EGCG-fatty acid derivatives for the prevention and treatment of viral infections.
format Online
Article
Text
id pubmed-6222519
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62225192018-11-13 Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters Kaihatsu, Kunihiro Yamabe, Miyuki Ebara, Yasuhito Molecules Review Epigallocatechin-3-O-gallate (EGCG) is the major catechin component of green tea (Cameria sinensis), and is known to possess antiviral activities against a wide range of DNA viruses and RNA viruses. However, few studies have examined chemical modifications of EGCG in terms of enhanced antiviral efficacy. This paper discusses which steps of virus infection EGCG interferes with, citing previous reports. EGCG appears most likely to inhibits the early stage of infections, such as attachment, entry, and membrane fusion, by interfering with viral membrane proteins. According to the relationships between structure and antiviral activity of catechin derivatives, the 3-galloyl and 5′-OH group of catechin derivatives appear critical to antiviral activities. Enhancing the binding affinity of EGCG to virus particles would thus be important to increase virucidal activity. We propose a newly developed EGCG-fatty acid derivative in which the fatty acid on the phenolic hydroxyl group would be expected to increase viral and cellular membrane permeability. EGCG-fatty acid monoesters showed improved antiviral activities against different types of viruses, probably due to their increased affinity for virus and cellular membranes. Our study promotes the application of EGCG-fatty acid derivatives for the prevention and treatment of viral infections. MDPI 2018-09-27 /pmc/articles/PMC6222519/ /pubmed/30262731 http://dx.doi.org/10.3390/molecules23102475 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kaihatsu, Kunihiro
Yamabe, Miyuki
Ebara, Yasuhito
Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters
title Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters
title_full Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters
title_fullStr Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters
title_full_unstemmed Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters
title_short Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters
title_sort antiviral mechanism of action of epigallocatechin-3-o-gallate and its fatty acid esters
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222519/
https://www.ncbi.nlm.nih.gov/pubmed/30262731
http://dx.doi.org/10.3390/molecules23102475
work_keys_str_mv AT kaihatsukunihiro antiviralmechanismofactionofepigallocatechin3ogallateanditsfattyacidesters
AT yamabemiyuki antiviralmechanismofactionofepigallocatechin3ogallateanditsfattyacidesters
AT ebarayasuhito antiviralmechanismofactionofepigallocatechin3ogallateanditsfattyacidesters